Description
Cardiologie
- Prevention of heart failureby Massimo Piepoli on 1 juin 2026 at 15h07
Eur Heart J. 2026 May 30:ehag362. doi: 10.1093/eurheartj/ehag362. Online ahead of print.ABSTRACTHeart failure (HF) remains a major cause of morbidity, mortality and costs for the healthcare systems worldwide, despite advances in diagnostic and therapeutic strategies. The enhancement of preventive measures is now a priority, but effective […]
- Role of Neuroimaging Before Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrestby Edmond Wong on 1 juin 2026 at 14h57
Catheter Cardiovasc Interv. 2026 May 31. doi: 10.1002/ccd.70681. Online ahead of print.ABSTRACTBACKGROUND: Patients presenting following out-of-hospital cardiac arrest (OOHCA) often require emergency coronary angiography. Presentations can be associated with syncope or head-trauma.AIMS: We investigated the impact and utility of pre-coronary […]
- Reciprocal Mechanisms Linking Cancer and Cardiovascular Disease: Emerging Paradigms in Onco-Cardiologyby Shanmugananth Elayaperumal on 28 avril 2026 at 17h12
Curr Pharm Des. 2026 Apr 10. doi: 10.2174/0113816128456103260310045856. Online ahead of print.ABSTRACTBACKGROUND: There is a dual causal relationship between cancer and Cardiovascular Disease (CVD) due to similar risk factors and overlapping convergent molecular mechanisms. Factors such as hypertension, diabetes, dyslipidemia, obesity, smoking, […]
- Large Language Models in Cardiology: Systematic Reviewby Moran Gendler on 28 avril 2026 at 17h11
JMIR Cardio. 2026 Apr 16;10:e76734. doi: 10.2196/76734.ABSTRACTBACKGROUND: Large language models (LLMs) are increasingly used in health care, but their role in cardiology has not yet been systematically evaluated.OBJECTIVE: This review aimed to assess the applications, performance, and limitations of LLMs across diverse cardiology tasks, including […]
- Soft robotic devices for cardiovascular medicineby Xing-Yu Ji on 28 avril 2026 at 17h10
Nat Rev Cardiol. 2026 Apr 17. doi: 10.1038/s41569-026-01287-7. Online ahead of print.ABSTRACTConventional, rigid simulators and therapeutic devices for cardiovascular disease have several fundamental limitations, such as poor biomimetic fidelity, substantial surgical invasiveness and mismatch at the tissue-device interface. Soft robotic devices, […]
- Bridging the Gap: Cardiac Magnetic Resonance Guidelines to Clinical Practice in Sport Cardiologyby Chi Yang Chen on 28 avril 2026 at 17h09
Magn Reson Imaging Clin N Am. 2026 May;34(2):187-196. doi: 10.1016/j.mric.2026.01.003. Epub 2026 Feb 20.ABSTRACTSports cardiology has emerged as a critical subspecialty within cardiovascular medicine, focusing on the prevention, diagnosis, and management of cardiovascular conditions in athletes and physically active individuals. As participation […]
Maladies du cœur
- C-reactive protein-to-albumin ratio and the mortality of patients with heart failure: a meta-analysisby Yan Wang on 1 juin 2026 at 15h46
BMC Cardiovasc Disord. 2026 May 29. doi: 10.1186/s12872-026-05983-7. Online ahead of print.ABSTRACTBACKGROUND: The C-reactive protein-to-albumin ratio (CAR) reflects the interplay between systemic inflammation and nutritional status, and has recently been proposed as a prognostic biomarker in heart failure (HF). However, its association with […]
- Huatuo Zaizao Pills improve myocardial ischemia by inhibiting extracellular calcium influxby Nannan Wang on 1 juin 2026 at 15h39
Chin J Nat Med. 2026 Jun;24(6):745-756. doi: 10.1016/S1875-5364(26)61096-5.ABSTRACTCoronary heart disease (CHD), characterized by impaired coronary artery function, often results in myocardial ischemia, hypoxia, and necrosis, with clinical manifestations such as angina pectoris. Vascular smooth muscle cell (VSMC) hypercontraction, primarily […]
- Organ-Specific Efficacy of Postischemic Empagliflozin in Acute Stroke and Myocardial Infarction Using Preclinical Modelsby Jiajun Li on 1 juin 2026 at 15h10
J Am Heart Assoc. 2026 May 29:e047087. doi: 10.1161/JAHA.125.047087. Online ahead of print.ABSTRACTBACKGROUND: Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, has demonstrated cardioprotective and neuroprotective effects in preclinical myocardial infarction (MI) and ischemic stroke settings by reducing acute myocardial and cerebral […]
- Efficacy of SGLT2 Inhibitors in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: An Updated Systematic Review and Meta-Analysisby Tingyu Wang on 1 juin 2026 at 15h05
Ann Pharmacother. 2026 May 31:10600280261447498. doi: 10.1177/10600280261447498. Online ahead of print.ABSTRACTBACKGROUND: Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) constitute a substantial clinical burden with limited therapeutic options. While sodium-glucose […]
- Optimal duration of dual antiplatelet therapy for secondary stroke prevention: A systematic review and meta-analysisby André Richard da Silva Oliveira Filho on 1 juin 2026 at 14h59
J Clin Neurosci. 2026 May 31;151:112114. doi: 10.1016/j.jocn.2026.112114. Online ahead of print.ABSTRACTBACKGROUND: Dual antiplatelet therapy (DAPT) is recommended for secondary prevention after minor ischemic stroke or high-risk transient ischemic attack (TIA). Although short-term DAPT is widely used, uncertainty remains regarding how the balance […]
- Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in chronic obstructive pulmonary disease: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trialsby Chih-Chung Lin on 1 juin 2026 at 14h58
J Int Med Res. 2026 May;54(5):3000605261452493. doi: 10.1177/03000605261452493. Epub 2026 May 31.ABSTRACTObjectiveSodium-glucose cotransporter 2 inhibitors are widely used in the management of diabetes mellitus and have demonstrated substantial cardiovascular and renal protective effects, particularly in patients with heart failure. However, their […]
Maladies du cœur & Soins infirmiers
- Heart failure nursing priorities for the new graduate nurse.by Guerin, April on 28 avril 2026 at 17h34
Nursing Made Incredibly Easy!; 05/01/2026(AN 193122487); ISSN: 15445186CINAHL Complete
Chirurgies cardiaques
- Severe Aortic Stenosis Is Associated With Left Atrial Prothrombotic Flow That Persists Despite Valve Replacementby Marco Spartera on 28 avril 2026 at 17h49
J Am Heart Assoc. 2026 Apr 21;15(8):e045174. doi: 10.1161/JAHA.125.045174. Epub 2026 Apr 9.ABSTRACTBACKGROUND: Severe aortic stenosis (AS) is associated with ischemic stroke independently of atrial fibrillation or other causes. Even after aortic valve replacement (AVR), patients remain affected by a 6% 5-year stroke rate with knowledge gaps in the […]
- Efficacy of Surgeon-Administered Regional Anesthesia in Cardiac Surgery: A Double-Blinded, 2-Center, Randomized, Placebo-Controlled Trialby Jonas Juel Rasmussen on 28 avril 2026 at 17h46
J Cardiothorac Vasc Anesth. 2026 Mar 27:S1053-0770(26)00271-5. doi: 10.1053/j.jvca.2026.03.042. Online ahead of print.ABSTRACTOBJECTIVES: Managing pain after median sternotomy is a clinical challenge of balancing adequate pain relief with avoidance of excessive opioid consumption. While regional anesthesia techniques are increasingly recommended […]
- Feasibility of optical coherence tomography for localizing and quantifying paclitaxel deposition after drug-coated balloon angioplastyby Alexander B Crichton on 28 avril 2026 at 17h40
Int J Cardiol. 2026 Jul 15;455:134483. doi: 10.1016/j.ijcard.2026.134483. Epub 2026 Apr 9.ABSTRACTINTRODUCTION: Drug coated balloon (DCB) angioplasty aims to reduce restenosis rates. However, studies suggest that only 10-20% of the drug is delivered to the vessel wall. Given this significant barrier to success, intra-operative methods for […]
- Evaluation of clinical impact of ultra fast-track versus conventional extubation in patients undergoing nonemergency cardiac surgery: 'CARDU-FAST': A randomised clinical trialby Lourdes Montero Cruces on 28 avril 2026 at 17h37
Eur J Anaesthesiol. 2026 Apr 28. doi: 10.1097/EJA.0000000000002400. Online ahead of print.ABSTRACTBACKGROUND: Immediate extubation in the operating theatre (Ultra Fast-Track, UFT), compared with early extubation in the intensive care unit (ICU) (Fast-Track, FT), has been proposed as a strategy to improve postoperative recovery after cardiac […]
Chirurgies cardiaques & Soins infirmiers
Autre veille d’intérêt : Chirurgie – Soins infirmiers
- Nurse-led postoperative interventions in adult cardiac surgery: a systematic reviewby Stacey Matthews on 28 avril 2026 at 17h43
Eur J Cardiovasc Nurs. 2026 Apr 27:zvag112. doi: 10.1093/eurjcn/zvag112. Online ahead of print.ABSTRACTAIMS: The primary aim of this systematic review was to identify nurse-led clinical interventions evaluated in randomised controlled trials (RCT) for adults who had undergone cardiac surgery. The secondary aim was to assess the effectiveness of […]
Chirurgies vasculaires
- Comparison of Percutaneous Coronary Intervention Outcomes for in-Stent vs de Novo Chronic Total Occlusions: A Meta-Analysisby Qiongya Mao on 28 avril 2026 at 17h57
Ther Clin Risk Manag. 2026 Apr 15;22:576328. doi: 10.2147/TCRM.S576328. eCollection 2026.ABSTRACTBACKGROUND: Chronic coronary total occlusion (CTO) represents a formidable challenge in interventional cardiology, occurring either within previously implanted stents (in-stent CTO) or in non-stented native vessels (de novo CTO). We aimed to compare […]
- Impact of Extravalvular Remodeling on Wearable Smartwatch-Recorded Physical Activity in Patients Undergoing Transcatheter Aortic Valve Implantation for Severe Symptomatic Aortic Stenosisby Vitaliy Androshchuk on 28 avril 2026 at 17h55
J Am Heart Assoc. 2026 Apr 21;15(8):e047277. doi: 10.1161/JAHA.125.047277. Epub 2026 Apr 7.ABSTRACTBACKGROUND: Wearable smartwatches enable objective quantification of physical activity. This study evaluated the association of extravalvular cardiac damage in aortic stenosis with smartwatch-recorded physical activity before and after transcatheter […]
- Supra-Annular Versus Intra-Annular Devices for Transcatheter Aortic Valve-in-Valve Replacement: The PANDORA International Registryby Antonio Popolo Rubbio on 28 avril 2026 at 17h54
J Am Heart Assoc. 2026 Apr 21;15(8):e046180. doi: 10.1161/JAHA.125.046180. Epub 2026 Apr 16.ABSTRACTBACKGROUND: As transcatheter aortic valve replacement (TAVR) expands to younger, lower-risk populations, the need for repeat procedures due to valve degeneration is expected to increase. TAVR-in-TAVR has emerged as a feasible strategy, although […]
- Predicting Factors Affecting Postoperative Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Surgery Using Machine Learning Methods: A Systematic Reviewby Alireza Jafarkhani on 28 avril 2026 at 17h53
Health Sci Rep. 2026 Apr 22;9(4):e72391. doi: 10.1002/hsr2.72391. eCollection 2026 Apr.ABSTRACTBACKGROUND AND AIM: Nowadays, coronary artery bypass graft (CABG) surgery has become a common method for treating coronary artery diseases. This surgery requires a long post-operative length of stay (PLOS) in the hospital. The purpose of this study was […]
- Prognostic impact of conduction disturbance subtypes after transcatheter aortic valve implantationby Shogo Okita on 28 avril 2026 at 17h53
Int J Cardiol. 2026 Jul 15;455:134495. doi: 10.1016/j.ijcard.2026.134495. Epub 2026 Apr 13.ABSTRACTBACKGROUND: Conduction disturbances (CD) are common in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). Although various types of CD occur, the prognostic differences among CD subtypes, including transient […]
Chirurgies vasculaires & Soins infirmiers
Autre veille d’intérêt : Chirurgie – Soins infirmiers
- Impact of Nurse-Led Cardiovascular Risk Assessment and Management Program on 1-Year Outcomes in Patients on Hemodialysis Post Percutaneous Coronary Intervention.by Zhao, Wanting; Zhao, Weiqiu; Sun, Xiaodan on 28 avril 2026 at 18h02
Journal of Cardiovascular Nursing; 05/01/2026(AN 192934398); ISSN: 08894655CINAHL Complete
Associations
- Author Correction to: "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology 41 (2025) 1857-1874]"by Primary Panel: on 28 avril 2026 at 17h13
Can J Cardiol. 2026 Apr 6:S0828-282X(26)00275-8. doi: 10.1016/j.cjca.2026.03.026. Online ahead of print.NO ABSTRACTPMID:41956442 | DOI:10.1016/j.cjca.2026.03.026
- Optimal lifelong roadmap post-ACS. A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESCby Roberto F E Pedretti on 28 avril 2026 at 17h08
Eur J Prev Cardiol. 2026 Apr 22:zwag236. doi: 10.1093/eurjpc/zwag236. Online ahead of print.ABSTRACTAcute coronary syndromes (ACS) remain a major cause of mortality and morbidity across Europe, with long-term outcomes still suboptimal despite advances in acute care. Current clinical guidelines primarily focus on the immediate post-event phase, […]
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


